CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 83 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 473.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$51,000
+34.2%
367,7000.0%0.00%
Q4 2018$38,000
-55.3%
367,7000.0%0.00%
Q3 2018$85,000
+1.2%
367,7000.0%0.00%
Q2 2018$84,000
-36.4%
367,7000.0%0.00%
Q1 2018$132,0000.0%367,7000.0%0.00%
Q4 2017$132,000
-13.7%
367,7000.0%0.00%
Q3 2017$153,000
-18.6%
367,7000.0%0.00%
Q2 2017$188,000
-11.3%
367,7000.0%0.00%
Q1 2017$212,000
-8.2%
367,7000.0%0.00%
Q4 2016$231,000
-31.5%
367,7000.0%0.00%
-100.0%
Q3 2016$337,000
+72.8%
367,7000.0%0.00%
Q2 2016$195,000
-43.8%
367,7000.0%0.00%
-100.0%
Q1 2016$347,000
-29.0%
367,7000.0%0.00%0.0%
Q4 2015$489,000
-41.6%
367,7000.0%0.00%0.0%
Q3 2015$838,000
+41.6%
367,7000.0%0.00%0.0%
Q2 2015$592,000
-6.9%
367,7000.0%0.00%0.0%
Q1 2015$636,0000.0%367,7000.0%0.00%0.0%
Q4 2014$636,000
+31.1%
367,7000.0%0.00%0.0%
Q3 2014$485,000
-10.8%
367,7000.0%0.00%0.0%
Q2 2014$544,000
-13.0%
367,7000.0%0.00%0.0%
Q1 2014$625,000
-16.2%
367,7000.0%0.00%0.0%
Q4 2013$746,000
-24.4%
367,700
-1.3%
0.00%
-50.0%
Q3 2013$987,000
+12.4%
372,600
+13.3%
0.00%0.0%
Q2 2013$878,000328,8000.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2014
NameSharesValueWeighting ↓
Sowell Financial Services LLC 1,507,457$593,0000.17%
Harel Insurance Investments & Financial Services Ltd. 780,000$398,0000.03%
Spark Investment Management LLC 353,400$180,0000.01%
LifePlan Financial Group, Inc 28,810$15,0000.01%
Greenwich Wealth Management LLC 60,066$31,0000.01%
SHINE INVESTMENT ADVISORY SERVICES INC 19,608$10,0000.01%
Virtu KCG Holdings LLC 336,414$172,0000.01%
LYNCH & ASSOCIATES/IN 18,000$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$331,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 377,875$193,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders